Is a generic version of Biktarvy available in the U.S.?
No, a generic version of Biktarvy is not yet available in the U.S. [1].
When might a generic Biktarvy become available?
The earliest a generic version of Biktarvy could become available is around 2031, based on patent information. However, patent challenges or other legal developments could alter this timeline [1].
What are the key patents protecting Biktarvy?
Biktarvy is protected by several patents. For instance, U.S. Patent No. 9,327,005, which covers specific formulations, is a significant patent [1]. Other patents related to manufacturing processes and methods of use also contribute to its market exclusivity [1].
Can drug patent challenges affect generic availability?
Yes, drug patent challenges can significantly impact when a generic version of a drug becomes available. If patent litigation is successful, it could lead to an earlier generic entry than initially anticipated [1]. Conversely, if patents are upheld, exclusivity could be extended [1]. DrugPatentWatch.com tracks these patent landscapes and potential challenges for many medications [1].
Who manufactures Biktarvy?
Biktarvy is manufactured by Gilead Sciences, Inc. [1].